#biopharma

[ follow ]
#ai-in-science #protein-structure #drug-development #mass-spectrometry #glp-1 #ma #obesity-drugs
Science
fromTechCrunch
22 hours ago

AI is spitting out more potential drugs than ever. This start-up wants to figure out which ones matter. | TechCrunch

AI's impact in science is exemplified by DeepMind's protein structure predictions, but characterizing treatment candidates remains a significant challenge.
Medicine
from24/7 Wall St.
3 weeks ago

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

The GLP-1 revolution is driving biopharma M&A strategies, with companies like Viking Therapeutics and Structure Therapeutics as prime acquisition targets.
fromBoston.com
3 weeks ago

Major pharmaceutical company to cut nearly 250 Massachusetts jobs

The layoffs are part of a transformation plan approved by Takeda's board on March 25, expected to generate more than 200 billion Japanese yen in annualized savings by fiscal 2028, or about $1.25 billion.
Boston
Law
fromThe Verge
8 months ago

Errors found in US judge's withdrawn decision stink of AI

A U.S. district court judge withdrew his decision due to errors including fake quotes and incorrect case information.
[ Load more ]